Regulatory Updates on Biosimilars

Competitions and/or success in the present pharma industry are determined by the winning patent strategy which mostly pertains to the generic market entry. Generic and branded drug manufacturers both the patent strategy proximally belongs to the Hatch-Waxman Act statutory scheme and ANDA litigations. The Hatch-Waxman Act enacted in 1984 with amendment in 2003 facilitated the entry of generics at an early stage-thereby finishing the battle of branded generic ANDA of blockbuster drugs. All the same the Biologics Price Competition and Innovation (BPCI) Act has maximized the branded-generic patent duel in the biologics realm by imposing a litigated framework on follow-on-biologics.

An FDA analysis of drug prices from 1999 to 2004 found that the discount from generic competition was just 6% with one generic competitor, but jumps to 48% with two generic competitors, 56% with three, 61% with four and 67% with five generic producers in a market. Within 2 years of the expiration of the patent of the popular drug Zantac in 1997, generics of Zantac accounted 90% of the treatment’s total sales, and the price for patients was about 10% of its pre-generic price. European patents on biologic treatments began to expire in 2000, and in April 2006, Sandoz and Biopartners successfully received EMEA approval for the first European biogenerics, two products containing human growth hormone.

    Related Conference of Regulatory Updates on Biosimilars

    August 22-23, 2022

    2nd Annual Congress on Hospital and Clinical Pharmacy

    Dublin, Ireland
    August 24-25, 2022

    5th International Conference on Neonatology and Perinatology

    Prague, Czech Republic
    August 25-26, 2022

    International Conference on Bio Pharmaceutics

    Yokohama, Japan
    August 28-28, 2022

    8th Webinar on Pharmacology and Toxicology

    London, UK
    August 30-31, 2022

    21st Medicinal & PharmaceuticalSciences Congress

    Osaka, Japan
    September 02-03, 2022

    37th World Congress on Pharmacology and Therapeutics

    Stockholm, Sweden
    September 05-06, 2022

    19th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 12-13, 2022

    World Congress on Medicinal Chemistry and Computer Aided Drug Design

    Prague, Czech Republic
    September 16-17, 2022

    2nd Natural Medicines and Pharmaceutical Research

    New York, USA
    September 22-23, 2022

    Pharma Biotech Expo 2022

    Toronto, Canada
    September 29-30, 2022

    2nd World Congress on Rare Diseases & Orphan Drugs

    Lisbon, Portugal
    September 29-30, 2022

    7th International Conference on Future Pharma and Innovations

    Lisbon, Portugal
    October 05-06, 2022

    2nd International Congress on Drug Delivery

    Bangkok, Thailand
    October 10-11, 2022

    18th Annual Congress on Pharmacology and Toxicology

    Paris, France
    October 17-18, 2022

    3rd Annual Congress on Antibiotics and Bacterial Infections

    Prague, Czech Republic
    October 24-25, 2022

    22nd Annual Pharma Middle East Congress

    Dubai, UAE
    October 24-25, 2022

    17th World Conference on Pharmaceutical Chemistry

    Dublin, Ireland
    November 10-11, 2022

    2nd World Biosimilars & Biologics Congress

    Vancouver, Canada
    November 15-16, 2022

    10th International Conference on Clinical Trials

    Barcelona, Spain
    November 16-17, 2022

    2nd World Congress on Biologics and Biosimilars

    Hanoi, Vietnam
    November 21-22, 2022

    24th World Congress On Pharmaceutical Research and Drug Discovery

    Singapore City, Singapore
    November 22-23, 2022

    European Conference on Advance Clinical Trials and Research

    Amsterdam, Netherlands
    December 05-06, 2022

    World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 07-08, 2022

    9th Asian Herbal and Traditional Medicine summit

    Paris, France
    December 07-08, 2022

    14th World Congress on Personalized Medicine and Novel Therapy

    Singapore City, Singapore
    December 12-13, 2022

    5th International Pharmacy and Pharmaceutical Conference

    Dublin, Ireland
    March 10-11, 2023

    Global Pharmaceutical and Pharma Industry Conference

    Brussels, Belgium
    March 13-14, 2023

    33rd Annual European Pharma Congress

    Frankfurt, Germany
    April 03-04, 2023

    16th European Biosimilars Congress

    Barcelona, Spain
    May 07-08, 2023

    Advanced-Materials 2023

    Valencia, Spain
    May 22-23, 2023

    3rd Global Summit on Pharmaceutical Research

    Berlin, Germany
    May 24-25, 2023

    8th Pharmaceutical Chemistry Conference

    Paris, France

    Regulatory Updates on Biosimilars Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in